P. Krasochko, Y. P. Yaromchyk, P. Krasochko, V. Krasochko, Y. Shashkova, N. V. Sinitsa, O. Tarasov
{"title":"Adjuvantas in construction of mixed vaccines against infectious enterites of calves","authors":"P. Krasochko, Y. P. Yaromchyk, P. Krasochko, V. Krasochko, Y. Shashkova, N. V. Sinitsa, O. Tarasov","doi":"10.31073/vet_biotech35-11","DOIUrl":"https://doi.org/10.31073/vet_biotech35-11","url":null,"abstract":"Introduction. an etiology of gastrointestinal tract diseases of calves the main role is played by viruses of infectious rhinotracheitis, diarrhea, rotavirus and coronavirus infection, escherichiosis and salmonellosis. The main method of their control of of adjuvants to increase their immunogenicity. A number of adjuvants – mineral (an aluminum hydroxide, potassium alum), oil (an incomplete Freund's adjuvant, эмульсиген, montanida, Marcala), natural polysaccharides is known (bacterial lipopolysaccharides, the activated cellulose) are known. In this regard selection of optimum adjuvant when designing vaccines is a current problem in biotechnology. vaccines against infectious gastroenteritis of calves, was established that all adjuvants had a positive impact on biosynthesis of specific antibodies. At the same time a vaccinated animals antiserum capacity increased by 4-7 log 2 . Conclusions and prospects of further researches. When choosing optimum adjuvant in the designed vaccines against gastroenteritis of an infectious etiology of calves, more pronounced stimulation of a humoral immune response were received when using oil IZA-15 and IZA-25 adjuvant.","PeriodicalId":274594,"journal":{"name":"Bulletin \"Veterinary biotechnology\"","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129230146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Modern methods of foot-and-mouth disease diagnosis (review)","authors":"Z. Drozhzhe, Ia.N. Dzuba, G. Kyivska","doi":"10.31073/VET_BIOTECH38-05","DOIUrl":"https://doi.org/10.31073/VET_BIOTECH38-05","url":null,"abstract":"development, improvement and application of modern methods for the diagnosis of FMD (PCR, ELISA). Results of research and discussion. Generally, a suspected case of FMD can be identified based on observations of clinical signs. However, diagnoses based on clinical symptoms are highly unreliable, because several other diseases share similar symptoms as FMD, which include swine vesicular disease (SVD), vesicular stomatitis and vesicular exanthema. Swine are vulnerable to vesicular stomatitis, SVD, and FMD, whereas cattle are vulnerable to vesicular stomatitis and FMD, all of which could not be distinguished based on clinical symptoms. Conventional techniques such as complement fixation test (CFT), virus isolation test, virus neutralization test (VNT), and ELISA are routinely used to detect FMDV in clinical samples. Advancement in molecular techniques accelerates rapid and accurate diagnoses of FMDV through detection of the viral RNA. In this article, the most recent advancements in reverse transcription-polymerase chain reaction (RT-PCR) and RT-loop-mediated isothermal amplification (RT-LAMP)-based methods are thoroughly reviewed. Lastly, the roles of lateral flow immunochromatographic (LFI) test strips in FMDV diagnosis are also discussed. Conclusions and prospects for further research. Various diagnostic methods ranging from conventional such as virus isolation and competitive- and blocking-antigen ELISA to molecular-based methods such as RT-PCR and RT-LAMP have been developed over the years. Although ELISA-based methods have good diagnostic sensitivity and specificity, molecular detection methods have the advantage of higher analytical sensitivity for the detection of minimal viral RNA.","PeriodicalId":274594,"journal":{"name":"Bulletin \"Veterinary biotechnology\"","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132263825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
O. Nechyporenko, A. Berezovskiy, O. Shkromada, L. Ulko, S. Nychyk
{"title":"Assessment of ADG disinfectant cumulative and metabolic rate effect in\u0000 laboratory animals","authors":"O. Nechyporenko, A. Berezovskiy, O. Shkromada, L. Ulko, S. Nychyk","doi":"10.31073/vet_biotech36-13","DOIUrl":"https://doi.org/10.31073/vet_biotech36-13","url":null,"abstract":"days; significant increase in the coefficients of mass of hematopoietic organs, such as liver – by 23.8%, spleen – by 15.2% and mass of kidneys by 30.1% (p <0.001), compared with similar indicators in control group. The ADG side effects to organism of laboratory animals is under our study.","PeriodicalId":274594,"journal":{"name":"Bulletin \"Veterinary biotechnology\"","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129990448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}